date,title,body,url,image,source
2020-11-09T08:01:00+00:00,DERMALA Announces $6.73 Million Series A Financing to Expand and Scale Company's Personalized Microbiome-Based Solutions for Acne and Other Skin Conditions - Business Wire,"About DERMALA. DERMALA, Inc. is a privately-held consumer dermatology company leveraging scientific understanding of the human microbiome to develop novel solutions for acne and other skin conditions.",https://www.businesswire.com/news/home/20201109005312/en/DERMALA-Announces-6.73-Million-Series-A-Financing-to-Expand-and-Scale-Companyâ€™s-Personalized-Microbiome-Based-Solutions-for-Acne-and-Other-Skin-Conditions,,Business Wire
2022-03-24T07:00:00+00:00,DERMALA CEO AND FOUNDER INVITED AS SPEAKER AND PANELIST TO TWO UPCOMING INDUSTRY CONFERENCES - Markets Insider,"DERMALA, Inc. is a San Diego-based company leveraging a scientific understanding of the human microbiome and data analytics to develop novel personalized treatments for chronic skin conditions.",https://markets.businessinsider.com/news/stocks/dermala-ceo-and-founder-invited-as-speaker-and-panelist-to-two-upcoming-industry-conferences-1031304308,,Business Insider
